N Verses Capital, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
N Verses Capital, LLC
- $219 Billion
- Q3 2024
A detailed history of N Verses Capital, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 700 shares of ARWR stock, worth $13,671. This represents 0.01% of its overall portfolio holdings.
Number of Shares
700
Previous 3,700
81.08%
Holding current value
$13,671
Previous $96.2 Million
85.9%
% of portfolio
0.01%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding ARWR
# of Institutions
294Shares Held
90.8MCall Options Held
155KPut Options Held
426K-
Black Rock Inc. New York, NY15.7MShares$306 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$239 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$174 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$124 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$95.4 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.07B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...